Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis.
School of Pharmacy, Master Program in Clinical Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
Chin-Wei
CW
Hsu
School of Pharmacy, Master Program in Clinical Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC; Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC. Electronic address: yabihu@kmu.edu.tw.
Yaw-Bin
YB
Huang
School of Pharmacy, Master Program in Clinical Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC; Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC. Electronic address: u99830003@kmu.edu.tw.
Chung-Yu
CY
Chen
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002545:Brain Ischemia / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
Aspirin; Atrial fibrillation; Dialysis; Warfarin